Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Revenue: 2009-2025

Historic Revenue for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $15.9 million.

  • Rockwell Medical's Revenue fell 43.75% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.6 million, marking a year-over-year decrease of 23.60%. This contributed to the annual value of $101.5 million for FY2024, which is 21.38% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Revenue is $15.9 million, which was down 0.90% from $16.1 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Revenue registered a high of $28.3 million during Q3 2024, and its lowest value of $15.1 million during Q2 2021.
  • Over the past 3 years, Rockwell Medical's median Revenue value was $22.1 million (recorded in 2023), while the average stood at $21.5 million.
  • In the last 5 years, Rockwell Medical's Revenue spiked by 42.88% in 2024 and then tumbled by 43.75% in 2025.
  • Rockwell Medical's Revenue (Quarterly) stood at $15.3 million in 2021, then increased by 25.97% to $19.3 million in 2022, then rose by 14.39% to $22.1 million in 2023, then increased by 11.64% to $24.7 million in 2024, then slumped by 43.75% to $15.9 million in 2025.
  • Its Revenue was $15.9 million in Q3 2025, compared to $16.1 million in Q2 2025 and $18.9 million in Q1 2025.